Insider Trading: Aegerion Pharmaceuticals Inc (AEGR.O)
AEGR.O on Nasdaq
62.34USD
17 Jun 2013
62.34USD
17 Jun 2013
Price Change (% chg)
$-4.47 (-6.69%)
$-4.47 (-6.69%)
Prev Close
$66.81
$66.81
Open
$67.34
$67.34
Day's High
$68.60
$68.60
Day's Low
$62.01
$62.01
Volume
1,058,994
1,058,994
Avg. Vol
666,462
666,462
52-wk High
$75.69
$75.69
52-wk Low
$12.86
$12.86
| PERCEPTIVE ADVISORS L L C | Options Exercised: 0 | ||
| Trade Date: | Monday, 19 Nov 2012 | Price: | 21.01 |
| Title: | Beneficial Owner of More than 10% Class | Shares Held: | 2,565,293 |
| Type Traded: | Indirect | Net Change in Shares This Filing: | 150,000 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 161 |
| Total Shares Held: | 31,260,842 |
| 3 Mo. Net Change: | 6,251,537 |
| # New Positions: | 49 |
| # Closed Positions: | 15 |
| # Increased Positions: | 118 |
| # Reduced Positions: | 48 |
| # Net Buyers: | 70 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
David Scheer |
60 | 2005 | Independent Chairman of the Board |
Marc Beer |
48 | 2010 | Chief Executive Officer, Director |
Mark Fitzpatrick |
50 | 2011 | Chief Financial Officer |
Anne Cook |
50 | 2011 | Senior Vice President, General Counsel, Secretary |
Martha Carter |
59 | 2011 | Chief Regulatory Officer and Senior Vice President |
Mark Sumeray |
46 | 2011 | Chief Medical Officer |
Anne VanLent |
2013 | Director | |
Sol Barer |
2011 | Independent Director | |
Antonio Gotto |
76 | 2006 | Independent Director |
Sandford Smith |
65 | 2012 | Independent Director |
Paul Thomas |
56 | 2011 | Independent Director |
Amanda Murphy |
IR Contact Officer |

